159 related articles for article (PubMed ID: 48234)
1. [Is the prostatic adenoma of hormonal origin].
Bercovici JP; Morfin R; Charles JF
Nouv Presse Med; 1975 Feb; 4(7):475-8. PubMed ID: 48234
[TBL] [Abstract][Full Text] [Related]
2. Benign prostatic hyperplasia: etiological considerations.
Walsh PC
Prog Clin Biol Res; 1976; 6():1-8. PubMed ID: 66685
[TBL] [Abstract][Full Text] [Related]
3. Androgens and estrogens in the plasma and prostatic tissue of normal dogs and dogs with benign prostatic hypertrophy.
Lloyd JW; Thomas JA; Mawhinney MG
Invest Urol; 1975 Nov; 13(3):220-22. PubMed ID: 53217
[TBL] [Abstract][Full Text] [Related]
4. Concentration of dihydrotestosterone and 3 alpha-androstanediol in naturally occurring and androgen-induced prostatic hyperplasia in the dog.
Moore RJ; Gazak JM; Quebbeman JF; Wilson JD
J Clin Invest; 1979 Oct; 64(4):1003-10. PubMed ID: 90055
[TBL] [Abstract][Full Text] [Related]
5. [Pathogenesis of prostatic hyperplasia in normal and adenomatous glands of men and dogs: 3-alpha reduction of dihydrotestesterone].
Jacob GH
Endokrinologie; 1977 Oct; 70(2):158-68. PubMed ID: 73458
[No Abstract] [Full Text] [Related]
6. Dihydrotestosterone in prostatic hypertrophy. II. The formation and content of dihydrotestosterone in the hypertrophic canine prostate and the effect of dihydrotestosterone on prostate growth in the dog.
Gloyna RE; Siiteri PK; Wilson JD
J Clin Invest; 1970 Sep; 49(9):1746-53. PubMed ID: 4194769
[TBL] [Abstract][Full Text] [Related]
7. Testosterone metabolism in prostate; formation of androstan-17-beta-ol-3-one and androst-4-ene-3, 17-dione, and inhibitory effect of natural and synthetic estrogens.
Shimazaki J; Kurihara H; Ito Y; Shida K
Gunma J Med Sci; 1965 Dec; 14(4):313-25. PubMed ID: 4162344
[No Abstract] [Full Text] [Related]
8. [5 alpha-dihydrotestosterone and prostatic adenoma].
Morfin R; Charles JF; Bercovici JP
J Urol Nephrol (Paris); 1978; 84(10-11):691-703. PubMed ID: 84877
[No Abstract] [Full Text] [Related]
9. Conversion of 3H-testosterone to dihydrotestosterone in human hypertrophic prostatic tissue.
Baranowska B; Zgliczyński S
Nuklearmedizin; 1979; 18(6):297-9. PubMed ID: 94161
[TBL] [Abstract][Full Text] [Related]
10. Androgen metabolism in the hypertrophic prostate.
Wilson JD; Gloyna RE; Siiteri PK
J Steroid Biochem; 1975; 6(3-4):443-5. PubMed ID: 52762
[No Abstract] [Full Text] [Related]
11. Some aspects of the pathogenesis of prostatic hyperplasia.
Tveter KJ
Acta Pathol Microbiol Scand Suppl; 1974; Suppl 248():167-74. PubMed ID: 4141576
[No Abstract] [Full Text] [Related]
12. Androgen assimilation by normal and hyperplastic dog prostate glands.
Mawhinney MG; Schwartz FL; Thomas JA; Lloyd JW
Invest Urol; 1974 Jul; 12(1):17-22. PubMed ID: 4135034
[No Abstract] [Full Text] [Related]
13. The effect of dutasteride on intraprostatic dihydrotestosterone concentrations in men with benign prostatic hyperplasia.
Wurzel R; Ray P; Major-Walker K; Shannon J; Rittmaster R
Prostate Cancer Prostatic Dis; 2007; 10(2):149-54. PubMed ID: 17189955
[TBL] [Abstract][Full Text] [Related]
14. [Recent results of prostatic adenoma research].
Kaufmann J
Z Urol Nephrol; 1975 Nov; 68(11):. PubMed ID: 58501
[No Abstract] [Full Text] [Related]
15. [Measurement of T and DHT contents in normal and diseased human prostate tissues].
Zhang Y; Ye L; Ding Q; Fang Z; Yao M; Shi D
Zhonghua Wai Ke Za Zhi; 2000 Jul; 38(7):545-7. PubMed ID: 11832106
[TBL] [Abstract][Full Text] [Related]
16. Dihydrotestosterone in prostatic hypertrophy. I. The formation and content of dihydrotestosterone in the hypertrophic prostate of man.
Siiteri PK; Wilson JD
J Clin Invest; 1970 Sep; 49(9):1737-45. PubMed ID: 4194768
[TBL] [Abstract][Full Text] [Related]
17. Prevalent decrease of the EGF content in the periurethral zone of BPH tissue induced by treatment with finasteride or flutamide.
Monti S; Sciarra F; Adamo MV; Toscano V; Trotta MC; Martini C; Lanzara S; Silverio FD
J Androl; 1997; 18(5):488-94. PubMed ID: 9349746
[TBL] [Abstract][Full Text] [Related]
18. 3alpha-Reduction of dihydrotestosterone in human normal and hypertrophic prostatic tissues.
Shida K; Shimazaki J; Ito Y; Yamanaka H; Nagai-Yuasa H
Invest Urol; 1975 Nov; 13(3):241-5. PubMed ID: 53218
[TBL] [Abstract][Full Text] [Related]
19. Prostatic growth: new insights into hormonal regulation.
McConnell JD
Br J Urol; 1995 Jul; 76 Suppl 1():5-10. PubMed ID: 7544215
[No Abstract] [Full Text] [Related]
20. Changes in dihydrotestosterone metabolism associated with the development of canine benign prostatic hyperplasia.
Isaacs JT; Coffey DS
Endocrinology; 1981 Feb; 108(2):445-53. PubMed ID: 6161001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
